C12N 2710/00022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/00022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 23 US grants and 32 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 32
- Assignees
- 30
- Inventors
- 68
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 1 | 3 |
| 2016 | 3 | 3 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 5 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chimeric protein toxins for expression by therapeutic bacteria2 Jun 2026US 12,642,873 B1
- Systems and methods for increasing efficiency of genome editing16 Jan 2024US 11,873,322 B2Yeda Research and Development Co. Ltd.
- Chimeric protein toxins for expression by therapeutic bacteria28 Sep 2021US 11,129,906 B1
- Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis20 Apr 2021US 10,981,977 B2Geneuro SA
- Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody28 Jul 2020US 10,723,787 B2Geneuro SA
- Modified long peptides suitable for use in immunisation16 Jul 2026US 2026/0200990 A1Isabella Pharma B.V.
- Compounds and methods for chemically tagging macromolecule cargo inside and outside of virus-like particles22 Jan 2026US 2026/0022351 A1The Trustees of Indiana University
- Mutant nudivirus insect control27 Nov 2025US 2025/0361493 A1University of Kentucky Research Foundation
- Inhibition of neuronal activity by means of potassium ion channels17 Apr 2025US 2025/0122261 A1
- mRNA-Based Vaccine Composition for Inducing Immune Response Against HIV and HPV15 Aug 2024US 2024/0269260 A1
Most cited
By later US patents
- Compositions and methods for the treatment or prevention of hepatitis B virus infection21US 8,722,054 B2GlobeImmune, Inc. · 2014
- Plant containing a gene construct comprising a chlorella virus promoter and a lac operator14US 6,395,965 B1Restoragen, Inc. · 2002
- Human and marmoset activating viruses7US 6,177,081 B1Pacific Biotech International, Inc. · 2001
- Yeast-based therapeutic for chronic hepatitis B infection5US 8,877,205 B2GlobeImmune, Inc. · 2014
- Compositions and methods for the treatment or prevention of hepatitis B virus infection5US 9,428,556 B2GlobeImmune, Inc. · 2016